Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2IW9

STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsESRF BEAMLINE ID14-2
Synchrotron siteESRF
BeamlineID14-2
Temperature [K]100
Detector technologyCCD
Collection date2002-11-23
DetectorADSC CCD
Spacegroup nameP 21 21 21
Unit cell lengths73.758, 134.100, 148.120
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution100.000 - 2.000
R-factor0.212
Rwork0.210
R-free0.24000
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)1h1s
RMSD bond length0.012
RMSD bond angle1.294
Data reduction softwareMOSFLM
Data scaling softwareSCALA
Phasing softwareMOLREP
Refinement softwareREFMAC (5.2.0019)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]47.1002.100
High resolution limit [Å]2.0002.000
Rmerge0.0600.350
Number of reflections97458
<I/σ(I)>61.4
Completeness [%]98.196.7
Redundancy2.62.5
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
17THE DROPLET CONTAINED PROTEIN AT A CONCENTRATION OF 10 MG ML-1 IN 40 MM HEPES PH 7.0 CONTAINING 1 MM DTT, 200 MM NACL, 5% V/V DMSO AND 1MM INHIBITOR. THE RESERVOIR SOLUTION CONTAINED 0.8 M KCL AND 1.2 M (NH4)2SO4 IN 40 MM HEPES PH 7.0 AND 5 MM DTT

225158

PDB entries from 2024-09-18

PDB statisticsPDBj update infoContact PDBjnumon